| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.081 | 0.08 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.073 | 0.1 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.066 | 0.1 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.062 | 0.2 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.055 | 0.2 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.053 | 0.2 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.042 | 0.3 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.039 | 0.4 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.041 | 0.4 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.039 | 0.4 |